Difference between revisions of "Papayannidis C, et al. Blood Cancer J. (2015) cited as Ref 593 in DOI: 10.1038/s41392-020-0110-5 (Q9856)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 5, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): e350-, #quickstatements; #temporary_batch_1590074839150) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / title | |||
| + | A phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma (English) | ||
| Property / title: A phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | e350- | ||
| Property / Page(s): e350- / rank | |||
| + | Normal rank | ||
Latest revision as of 15:46, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Papayannidis C, et al. Blood Cancer J. (2015) cited as Ref 593 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Papayannidis C
0 references
2015
0 references
Blood Cancer J.
0 references
5
0 references
A phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma (English)
0 references
e350-
0 references
